Lista de obras -

A feasibility study of weekly docetaxel with capecitabine in ovarian cancer: a promising combination of two active drugs with a potential for synergism.

artículo científico publicado en 2009

Accuracy of Risk Prediction Models for Breast Cancer and BRCA1/BRCA2 Mutation Carrier Probabilities in Israel

scientific article published on 01 August 2018

Age at diagnosis of cancer in 185delAG BRCA1 mutation carriers of diverse ethnicities: tentative evidence for modifier factors

artículo científico publicado en 2020

Breast cancer surveillance for BRCA1/2 mutation carriers - is "early detection" early enough?

scientific article published on 06 November 2019

Circulating cell-free DNA (cfDNA) levels in BRCA1 and BRCA2 mutation carriers: A preliminary study

artículo científico publicado en 2020

Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas

artículo científico publicado en 2012

Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma

scientific article published on 14 May 2009

Cranial irradiation in childhood mimicking neurofibromatosis type II.

artículo científico publicado en 2017

De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer

scientific article published on 01 April 2020

Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants

artículo científico publicado en 2020

Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer.

artículo científico publicado en 2007

Metastatic uterine leiomyosarcomas: a single-institution experience

artículo científico publicado en 2010

Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms

scientific article published on 12 April 2019

Mutational analysis of candidate genes in Israeli male breast cancer cases.

artículo científico publicado en 2018

Targeting the mammalian target of rapamycin in myxoid chondrosarcoma.

artículo científico publicado en 2008

The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: a prospective, randomized, phase II trial

scientific article published on 08 December 2011

The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients

artículo científico publicado en 2018

The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries

scientific article published on 26 July 2019

The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients

scientific article published on 31 July 2019

The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations

artículo científico publicado en 2018

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

artículo científico publicado en 2017

Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers

scientific article published on 29 November 2018

Lista de obras de

A feasibility study of weekly docetaxel with capecitabine in ovarian cancer: a promising combination of two active drugs with a potential for synergism.

Accuracy of Risk Prediction Models for Breast Cancer and BRCA1/BRCA2 Mutation Carrier Probabilities in Israel

Age at diagnosis of cancer in 185delAG BRCA1 mutation carriers of diverse ethnicities: tentative evidence for modifier factors

Breast cancer surveillance for BRCA1/2 mutation carriers - is "early detection" early enough?

Circulating cell-free DNA (cfDNA) levels in BRCA1 and BRCA2 mutation carriers: A preliminary study

Clinical activity of mTOR inhibition in combination with cyclophosphamide in the treatment of recurrent unresectable chondrosarcomas

Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma

Cranial irradiation in childhood mimicking neurofibromatosis type II.

De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer

Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants

Efficacy and toxicity of weekly topotecan in recurrent epithelial ovarian and primary peritoneal cancer.

Metastatic uterine leiomyosarcomas: a single-institution experience

Multigene panel testing in unselected Israeli breast cancer cases: mutational spectrum and use of BRCA1/2 mutation prediction algorithms

Mutational analysis of candidate genes in Israeli male breast cancer cases.

Targeting the mammalian target of rapamycin in myxoid chondrosarcoma.

The protective effect of zoledronic acid on bone loss in postmenopausal women with early breast cancer treated with sequential tamoxifen and letrozole: a prospective, randomized, phase II trial

The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients

The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries

The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients

The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.

Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers